Your Article Summary
Spherix Incorporated Appoints Dr. Ram Nimmagudda AS Director of New Business Development
Spherix, 09/14/09
Spherix Incorporated, an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology, and pharmaceutical companies, announced that, effective August, 2009, Ram R. Nimmagudda, Ph.D., has joined the company as Director of New Business Development.
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09
Position statement of the Portuguese Society of Nephrology on the clinical use of biotechnological drugs in renal patients
Portuguese Journal of Nephrology and Hypertension, 10/12/09
Orally Disintegrating Tablets: The Effect of Recent FDA Guidance on ODT Technologies and Applications
Pharmaceutical Technology, 10/14/09
Today in Execs on the Move...keeping you current
Receive free subspecialty "5-minute updates" via email
Astellas hires new vice president of compliance
Astellas, 09/11/09
Myriad Genetics Elects Louise Phanstiel and Lawrence Best to Its Board of Directors
Myriad, 09/22/09
New Chiefs at Axolotl, CliniComp
HealthDataManagement, 10/30/09
Article Search
Sponsor


See Latest Articles


